Zhi-jun Zhu
Clinical trials sponsored by Zhi-jun Zhu, explained in plain language.
-
Cell injection trial hopes to save livers too small for surgery
Disease control ENROLLING_BY_INVITATIONThis early-stage study tests whether injecting special liver cells into the belly can help people with small-for-size syndrome, a dangerous condition where a liver is too small to work properly. The trial will enroll 12 patients and focus on safety, checking for side effects and …
Phase: EARLY_PHASE1 • Sponsor: Zhi-Jun Zhu • Aim: Disease control
Last updated May 26, 2026 12:08 UTC
-
Smaller liver grafts could change transplant surgery
Disease control ENROLLING_BY_INVITATIONThis study looks at a new way to do liver transplants for people with severe portal hypertension. Instead of replacing the whole liver, doctors will use a smaller piece of a donor liver alongside the patient's own liver. The goal is to see if this method is safer and works as wel…
Sponsor: Zhi-Jun Zhu • Aim: Disease control
Last updated May 26, 2026 12:04 UTC
-
New study aims to improve survival in mismatched liver transplants
Disease control ENROLLING_BY_INVITATIONThis study looks at how well patients do after receiving a liver transplant from a living donor with a different blood type. It will track survival rates and organ rejection in 100 participants. The goal is to find ways to improve outcomes and reduce complications.
Sponsor: Zhi-Jun Zhu • Aim: Disease control
Last updated May 26, 2026 12:03 UTC